Atorvastatin Calcium



Indications and Reactions:

Role Indications Reactions
Primary
Hypercholesterolaemia 18.8%
Hypertension 17.4%
Blood Cholesterol Increased 13.2%
Diabetes Mellitus 7.6%
Hyperlipidaemia 7.1%
Product Used For Unknown Indication 6.6%
Ill-defined Disorder 3.5%
Dyslipidaemia 3.3%
Coronary Artery Disease 2.6%
Prophylaxis 2.5%
Blood Cholesterol Abnormal 2.2%
Myocardial Infarction 2.2%
Type 2 Diabetes Mellitus 2.1%
Blood Cholesterol 1.9%
Myocardial Ischaemia 1.9%
Angina Pectoris 1.4%
Depression 1.4%
Pain 1.4%
Drug Use For Unknown Indication 1.4%
Atrial Fibrillation 1.3%
Myalgia 15.3%
Rhabdomyolysis 15.1%
Drug Ineffective 8.6%
Pain In Extremity 7.9%
Muscle Spasms 7.3%
Nausea 4.5%
Drug Interaction 4.2%
Pain 4.2%
Rash 4.2%
Malaise 3.6%
Myocardial Infarction 3.2%
Pruritus 3.2%
Diarrhoea 2.8%
Blood Cholesterol Increased 2.6%
Weight Decreased 2.5%
Diabetes Mellitus 2.4%
Oedema Peripheral 2.4%
Dizziness 2.1%
Arthralgia 2.0%
Cerebral Infarction 2.0%
Secondary
Drug Use For Unknown Indication 19.0%
Product Used For Unknown Indication 15.1%
Blood Cholesterol Increased 14.9%
Hypertension 10.9%
Hypercholesterolaemia 7.0%
Hyperlipidaemia 4.8%
Diabetes Mellitus 4.4%
Rheumatoid Arthritis 2.5%
Type 2 Diabetes Mellitus 2.4%
Type Iia Hyperlipidaemia 2.4%
Cardiac Disorder 2.3%
Depression 2.2%
Coronary Artery Disease 2.0%
Dyslipidaemia 1.7%
Atrial Fibrillation 1.6%
Ischaemic Cardiomyopathy 1.5%
Myocardial Infarction 1.4%
Prophylaxis 1.4%
Asthma 1.3%
Blood Cholesterol Abnormal 1.3%
Rhabdomyolysis 15.9%
Myalgia 14.4%
Weight Decreased 6.2%
Completed Suicide 4.5%
Muscle Spasms 4.5%
Renal Failure 4.5%
Vitreous Detachment 4.3%
Vomiting 4.3%
Pain In Extremity 4.1%
Renal Failure Acute 4.1%
Rash 3.9%
Drug Ineffective 3.8%
Arthralgia 3.2%
Diarrhoea 3.2%
Hallucination 3.2%
Mesothelioma 3.2%
Myocardial Infarction 3.2%
Pruritus 3.2%
Weight Increased 3.2%
Pain 3.0%
Concomitant
Drug Use For Unknown Indication 33.1%
Product Used For Unknown Indication 18.3%
Hypertension 10.8%
Rheumatoid Arthritis 6.4%
Diabetes Mellitus 3.6%
Prophylaxis 2.9%
Type 2 Diabetes Mellitus 2.9%
Blood Cholesterol Increased 2.6%
Hypercholesterolaemia 2.2%
Insomnia 2.1%
Hiv Infection 2.1%
Pain 2.0%
Depression 1.8%
Hyperlipidaemia 1.7%
Atrial Fibrillation 1.6%
Osteoporosis 1.4%
Coronary Artery Disease 1.3%
Blood Cholesterol 1.3%
Acute Myocardial Infarction 1.1%
Angina Pectoris 1.0%
Vomiting 12.9%
Renal Failure Acute 8.1%
Myocardial Infarction 6.5%
Weight Decreased 6.3%
Insomnia 5.6%
Thrombocytopenia 5.3%
Pyrexia 4.9%
Urinary Tract Infection 4.8%
Renal Failure 4.7%
Pruritus 4.3%
Weight Increased 4.2%
Death 3.8%
Pneumonia 3.8%
Syncope 3.8%
Nausea 3.8%
Tremor 3.5%
Somnolence 3.5%
Dysgeusia 3.4%
Middle Insomnia 3.4%
Sepsis 3.2%
Interacting
Drug Use For Unknown Indication 29.2%
Product Used For Unknown Indication 17.4%
Hypercholesterolaemia 6.6%
Atrial Fibrillation 5.9%
Hyperlipidaemia 4.6%
Depression 4.3%
Hypertension 3.4%
Diabetes Mellitus 3.2%
Parkinson's Disease 3.2%
Ventricular Tachycardia 3.2%
Antiplatelet Therapy 2.5%
Osteomyelitis 2.5%
Leukocytosis 2.3%
Pain 2.3%
Gastric Ulcer 2.1%
Ill-defined Disorder 1.8%
Acute Coronary Syndrome 1.4%
Angina Pectoris 1.4%
Anticoagulant Therapy 1.4%
Blood Cholesterol Increased 1.4%
Drug Interaction 27.8%
Rhabdomyolysis 17.8%
Ventricular Dysfunction 7.8%
Aspartate Aminotransferase Increased 4.4%
Renal Failure Acute 4.4%
Electrocardiogram Qt Prolonged 3.3%
International Normalised Ratio Increased 3.3%
Myalgia 3.3%
Myocardial Infarction 3.3%
Paralysis 3.3%
Septic Shock 3.3%
Alanine Aminotransferase Increased 2.2%
Convulsion 2.2%
High Density Lipoprotein Decreased 2.2%
Low Density Lipoprotein Increased 2.2%
Musculoskeletal Stiffness 2.2%
Suicidal Behaviour 2.2%
Ventricular Arrhythmia 2.2%
Blood Creatine Phosphokinase Increased 1.1%
Cerebral Haematoma 1.1%